Maho Ishikawa

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study

Naoto Takahashi, Tetsuzo Tauchi, Kunio Kitamura et al. · International Journal of Hematology · 2017 · 94 citations

Medicine, Hematology, Oncology +3

How Is the Liver Primed or Sensitized for Alcoholic Liver Disease?

Hidekazu Tsukamoto, Yoshiyuki Takei, Craig J. McClain et al. · Alcoholism Clinical and Experimental Research · 2001 · 61 citations

Veterinary Medicine, Pathobiology, Pharmacology +17

Circulating antibodies to the surface antigens on colon epithelial cells in ulcerative colitis.

Toshifumi Hibi∥, Sadakazu Aiso, Maho Ishikawa et al. · PubMed · 1983 · 52 citations

Life Sciences, Immunology, Pathology +15

The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort

Eriko Sato, Noriyoshi Iriyama, Michihide Tokuhira et al. · Cancer Medicine · 2020 · 34 citations · Full text

Medicine, Hematology, Oncology +14

Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML

Tomoya Maeda, Fumiharu Yagasaki, Maho Ishikawa et al. · Blood · 2004 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +11